What is the most recent earnings date for EHC stock?
ENCOMPASS HEALTH CORP (EHC) last reported earnings on 2/5/2026.
ENCOMPASS HEALTH CORP (EHC) Earnings History & Surprises
NYSE:EHC • US29261A1007
Current stock price
101.43 USD
+1.06 (+1.06%)
At close:
101.43 USD
0 (0%)
After Hours:
EHC Earnings overview
Past quarterly earnings results for ENCOMPASS HEALTH CORP (EHC), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Apr 22, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $1.52
- Revenue Estimate
- 1.593B
Last Reported
Most Recent- Release Date
- Feb 5, 2026
- Period
- Q4 / 2025
- EPS Reported
- $1.46
- EPS Surprise
- 11.35%
- Revenue Surprise
- -0.73%
Beat Rate
Last 8 Quarters 81%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 1.46 | 1.31 | 11.35% | 24.79% | 1.545B | 1.556B | -0.73% | 9.94% |
| Q3 2025 | 1.23 | 1.21 | 1.94% | 19.42% | 1.478B | 1.495B | -1.17% | 9.36% |
| Q2 2025 | 1.40 | 1.22 | 14.64% | 26.13% | 1.458B | 1.441B | 1.16% | 12.03% |
| Q1 2025 | 1.37 | 1.20 | 14.11% | 22.32% | 1.455B | 1.444B | 0.79% | 10.59% |
| Q4 2024 | 1.17 | 1.04 | 12.94% | 23.16% | 1.405B | 1.395B | 0.72% | 12.69% |
| Q3 2024 | 1.03 | 0.95 | 8.15% | 19.77% | 1.351B | 1.341B | 0.75% | 11.94% |
| Q2 2024 | 1.11 | 1.02 | 8.41% | 16.84% | 1.301B | 1.318B | -1.27% | 9.61% |
| Q1 2024 | 1.12 | 0.95 | 18.50% | 27.27% | 1.316B | 1.286B | 2.33% | 13.41% |
| Q4 2023 | 0.95 | 0.82 | 15.27% | 7.95% | 1.247B | 1.249B | -0.18% | 9.63% |
| Q3 2023 | 0.86 | 0.78 | 10.73% | 28.36% | 1.207B | 1.206B | 0.07% | 10.78% |
| Q2 2023 | 0.95 | 0.75 | 26.24% | 6.74% | 1.187B | 1.172B | 1.29% | 11.73% |
| Q1 2023 | 0.88 | 0.71 | 23.91% | -9.28% | 1.16B | 1.156B | 0.38% | 9.54% |
| Q4 2022 | 0.88 | 0.84 | 4.80% | -9.28% | 1.137B | 1.132B | 0.47% | 9.09% |
| Q3 2022 | 0.67 | 0.64 | 3.96% | -34.95% | 1.09B | 1.075B | 1.35% | 7.79% |
| Q2 2022 | 0.89 | 0.98 | -8.88% | -23.93% | 1.063B | 1.357B | -21.70% | 45.31% |
| Q1 2022 | 0.97 | 0.93 | 4.69% | -7.62% | 1.059B | 1.337B | -20.77% | -13.91% |
| Q4 2021 | 0.97 | 1.06 | -8.40% | 4.30% | 1.043B | 1.32B | -21.02% | 664.86% |
| Q3 2021 | 1.03 | 1.07 | -3.63% | 32.05% | 1.011B | 1.327B | -23.83% | -13.89% |
| Q2 2021 | 1.17 | 0.98 | 19.03% | 277.42% | 731.2M | 1.277B | -42.74% | -31.92% |
| Q1 2021 | 1.05 | 0.83 | 26.53% | 20.69% | 1.23B | 1.243B | -1.01% | 4.09% |
| Q4 2020 | 0.93 | 0.86 | 7.72% | - | 136.3M | 1.217B | -88.80% | - |
| Q3 2020 | 0.78 | 0.75 | 3.90% | - | 1.174B | 1.192B | -1.52% | - |
| Q2 2020 | 0.31 | 0.39 | -20.41% | - | 1.074B | 1.066B | 0.76% | - |
| Q1 2020 | 0.87 | 0.86 | 0.97% | - | 1.182B | 1.212B | -2.48% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
10.51%
Max EPS beat (4)
14.64%
Min EPS beat (4)
1.94%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
0.01%
Max Revenue beat (4)
1.16%
Min Revenue beat (4)
-1.17%
Analysis
In the last 4 quarters, EHC has consistently beaten EPS estimates in all releases
EHC has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, EHC has beaten the EPS estimates by 10.5% on average.
In the last 4 quarters, EHC has beaten the revenue estimates by 0.0% on average.
Related analysis
ENCOMPASS HEALTH CORP / EHC Earnings FAQ
Did EHC stock beat earnings estimates in the most recent quarter?
ENCOMPASS HEALTH CORP (EHC) beat EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often ENCOMPASS HEALTH CORP beats earnings estimates?
In the last 4 quarters, ENCOMPASS HEALTH CORP (EHC) has beaten EPS estimates in 4 out of 4 releases.